Ziv-aflibercept in macular disease

BACKGROUND/AIMS: Aflibercept is an approved therapy for neovascular age-related macular degeneration (AMD) and diabetic macular oedema (DME). In vitro and in vivo studies did not detect toxicity to the retinal pigment epithelium cells using the approved cancer protein, ziv-aflibercept. Our purpose i...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Br J Ophthalmol
Main Authors: Mansour, Ahmad M, Al-Ghadban, Sara I, Yunis, Muhammad H, El-Sabban, Marwan E
Format: Artigo
Sprog:Inglês
Udgivet: BMJ Publishing Group 2015
Fag:
Clinical Science
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4518747/
https://ncbi.nlm.nih.gov/pubmed/25677668
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjophthalmol-2014-306319
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker